Product news from the 05/01/07 news brief
Duramed Pharmaceuticals, a subsidiary of Barr Pharmaceuticals, announced that the company has received two FDA approvals related to its Enjuvia ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.